Source: Annual Congress 2011 - Smoking-related disorders and smoking prevention
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Hamada, T. Samukawa, G. Tsukuya, K. Oketani, H. Tsubouchi, H. Inoue (Kagoshima, Japan). Surfactant protein D as a potential serum marker of pulmonary emphysema. Eur Respir J 2011; 38: Suppl. 55, 1559

Member's Comments

No comment yet.

Related content which might interest you: Surfactant proteins in interstitial pneumonia Source: Annual Congress 2005 - Lung-specific serum markers for interstitial lung diseases Year: 2005 Human napsin a is a useful serum marker of interstitial lung disease, compared to KL-6, and surfactant protein-D Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009 Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population Source: Eur Respir J 2001; 18: 482-490 Year: 2001 Serum surfactant protein D (SP-D) is a lung derived biomarker for COPD that is responsive to treatment with oral corticosteroids Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Serum surfactant protein D (SPD) as a specific marker for COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Serum surfactant protein D predicts the outcome of patients with idiopathic pulmonary fibrosis treated with pirfenidone Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 Surfactant protein-A (SP-A) expression in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 138s Year: 2007 Serum surfactant protein D: Biomarker of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Serum surfactant protein D (SP-D) and annual decline of diffusion capacity are prognostic factors for combined pulmonary fibrosis with emphysema (CPFE) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013 Serum levels of surfactant proteins in patients with combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2015 – IPF pathogenesis Year: 2015 Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene Source: Eur Respir J 2004; 24: 30-39 Year: 2004 Surfactant protein D is critical for local immunomodulation in the distal lung Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Serum surfactant protein D may predict the effect of pirfenidone in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Surfactant proteins in pulmonary alveolar proteinosis in adults Source: Eur Respir J 2004; 24: 426-435 Year: 2004 Differences in the immunolocalization of surfactant protein (SP)-A, SP-D and KL-6 in pulmonary alveolar proteinosis Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias Source: Eur Respir J 2007; 29: 134-137 Year: 2007 Surfactant protein A (SP-A) and alveolar complement activation in patients at-risk for ARDS Source: Eur Respir J 2002; 20: Suppl. 38, 375s Year: 2002 Lipid serum profile and copper content in serum and pulmonary tissue in experimental pulmonary emphysema Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010